会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明授权
    • Gene disruptions, compositions and methods relating thereto
    • 基因破坏,组合物和方法
    • US08207396B2
    • 2012-06-26
    • US13031009
    • 2011-02-18
    • Bobby Joe PayneMary Jean SparksWen Xiong
    • Bobby Joe PayneMary Jean SparksWen Xiong
    • G01N33/00
    • C12N15/8509A01K2217/075A01K2267/0306A01K2267/0362A01K2267/0375
    • The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444, PRO705, PRO1071, PRO1125, PRO1134, PRO1155, PRO1281, PRO1343, PRO1379, PRO1380, PRO1387, PRO1419, PRO1433, PRO1474, PRO1550, PRO1571, PRO1572, PRO1759, PRO1904, PRO35193, PRO4341, PRO4348, PRO4369, PRO4381, PRO4407, PRO4425, PRO4985, PRO4989, PRO5737, PRO5800, PRO5993, PRO6017, PRO7174, PRO9744, PRO9821, PRO9852, PRO9873, PRO10196, PRO34778, PRO20233, PRO21956, PRO57290, PRO38465, PRO38683 or PRO85161 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
    • 本发明涉及转基因动物,以及与基因功能表征相关的组合物和方法。 具体地,本发明提供转基因小鼠,其包括在PRO226,​​PRO257,PRO268,PRO290,PRO36006,PRO363,PRO365,PRO382,PRO444,PRO705,PRO1071,PRO1125,PRO1134,PRO1155,PRO1281,PRO1343,PRO1379,PRO1380,PRO1387,PRO1419中的中断 ,PRO1433,PRO1474,PRO1550,PRO1571,PRO1572,PRO1759,PRO1904,PRO35193,PRO4341,PRO4348,PRO4369,PRO4381,PRO4407,PRO4425,PRO4985,PRO4989,PRO5737,PRO5800,PRO5993,PRO6017,PRO7174,PRO9744,PRO9821,PRO9852,PRO9873 ,PRO10196,PRO34778,PRO20233,PRO21956,PRO57290,PRO38465,PRO38683或PRO85161基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防,改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管,内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。
    • 32. 发明授权
    • Gene disruptions, compositions and methods relating thereto
    • 基因破坏,组合物和方法
    • US07947866B2
    • 2011-05-24
    • US11577547
    • 2005-10-18
    • Mary Jean Sparks
    • Mary Jean Sparks
    • G01N33/00
    • A01K67/0276A01K2217/075A01K2227/105A01K2267/035
    • The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO194, PRO220, PRO241, PRO284, PRO331, PRO354, PRO355, PRO533, PRO541, PRO725, PRO937, PRO1014, PRO1120, PRO1182, PRO1325, PRO1382, PRO1410, PRO1555, PRO1556, PRO1760, PRO1787, PRO1868, PRO4326, PRO4332, PRO4346, PRO4400, PRO6003, PRO6094, PRO6244, PRO9820, PRO9828, PRO10274, PRO16090, PRO19644, PRO21340, PRO92165, PRO85143, PRO1124, PRO1026 or PRO23370 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
    • 本发明涉及转基因动物,以及与基因功能表征相关的组合物和方法。 具体地,本发明提供转基因小鼠,其包括PRO194,PRO220,PRO241,PRO284,PRO331,PRO354,PRO355,PRO533,PRO541,PRO725,PRO937,PRO1014,PRO1120,PRO1182,PRO1325,PRO1382,PRO1410,PRO1555,PRO1556,PRO1760中的中断 ,PRO1787,PRO1868,PRO4326,PRO4332,PRO4346,PRO4400,PRO6003,PRO6094,PRO6244,PRO9820,PRO9828,PRO10274,PRO16090,PRO19644,PRO21340,PRO92165,PRO85143,PRO1124,PRO1026或PRO23370基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防,改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管,内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。